ConCallIQ
Go Pro
DCAL Diversified 29 Jan 2026

Dishman Carbogen Amcis Limited — Q3 FY26

Dishman Carbogen Amcis reported Q3 FY26 revenue of ₹720 crore, up 5.5% YoY, but EBITDA margin contracted to 15.7% due to a shift toward lower-margin commercial supplies and early-phase development revenue.

neutral medium
Compare with...
Revenue ₹720 Cr +5.5%
EBITDA ₹113 Cr
PAT ₹-13 Cr
EBITDA Margin 15.7%
Duration 83 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Dishman Carbogen Amcis reported Q3 FY26 revenue of ₹720 crore, up 5.5% YoY, but EBITDA margin contracted to 15.7% due to a shift toward lower-margin commercial supplies and early-phase development revenue. The company posted a PAT loss of ₹12.97 crore for the quarter, impacted by a one-time finance cost of ₹11 crore from refinancing. Management maintained its full-year EBITDA margin guidance of 19.5-20%, supported by strong 9M margins of 19.4%. Key growth drivers include a co-investment ADC project with a Japanese customer (revenue expected to rise from CHF 22M in FY25 to CHF 40M in FY27), a ₹1,200 crore RFP pipeline for India operations targeting ₹500 crore revenue in 12-18 months, and a French subsidiary aiming for breakeven in FY27. Risks include delayed customer orders, high India debt of ₹750 crore, and execution dependency on converting RFPs into firm orders.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

Claim Ledger 79% answered

Did management answer the analysts?

12 analyst questions audited.

View Claim Ledger →
!Risks 4 risks

Risk Intelligence

Revenue concentration on single ADC customer

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

India RFP pipeline ₹1,200 Cr
N/A

RFPs submitted for India sites; 30-35% conversion expected, targeting ₹500 Cr revenue in 12-18 months.

ADC revenue from Japanese customer CHF 22M
+36% YoY

Revenue from ADC linker/payload for key customer; expected to reach CHF 30M in FY26 and CHF 40M in FY27.

India site capacity utilization 20-25%
N/A

Low utilization due to past regulatory issues; management targets 2.5x increase over 2-3 years.

French subsidiary revenue (9M) €7M
N/A

Revenue for first 9 months; full-year expected €9.5-10M, with FY27 target of €18M and breakeven.

Fast read

Guidance and risk preview

Top guidance Full-year EBITDA margin of 19.5-20%

Management reaffirmed FY26 EBITDA margin guidance of 19.5-20%, supported by 9M margin of 19.4%.

Top risk Revenue concentration on single ADC customer

A significant portion of growth depends on one Japanese customer's ADC molecule; any loss or delay would materially impact revenue.

View Risks →